Alzheimer’s sufferers are still facing barriers to using anti-dementia drugs, in spite of official guidance designed to improve access to them, campaigners have warned.The Alzheimer’s Society said some NHS bodies are either ignoring directions from the National Institute of Clinical Excellence (NICE) or limiting the number of patients being given the medication, in order to…